Abstract
Ankylosing spondylitis (AS) has well-defined renal complications, but urolithiasis has not been studied in detail. We aimed to evaluate the relation between AS and urolithiasis presence and the effect of this coexistence on the bone mineral status of patients. By dual-energy x-ray absorptiometry measurements at the femoral neck and lumbar vertebrae, we assessed the influence of urolithiasis, disease activity, and duration on bone mineral density (BMD) at different sites. Fifty-three AS patients and 25 control subjects were enrolled in the study. Mean age was 39.49±13.01 years for the AS group and 43.80±10.69 years for the control group, with no statistically significant difference. Patients were accepted as having active disease if two of the following were present: (1) symptomatic peripheral arthritis, (2) erythrocyte sedimentation rate greater than 30 mm/h, (3) C-reactive protein greater than 5 mg/L, and (4) dorsal–lumbar morning stiffness more than 60 min. The ratios of urinary stone presence were 11.32 and 12% for AS and control groups, respectively. We observed that a statistically significant difference in femur neck BMD between AS patients with or without urolithiasis was apparent. The lumbar BMD values were also lower in the urolithiasis subgroup but could not reach the statistical significance. There were no significant BMD alterations in the control group due to stone presence. Comparison of active–inactive disease groups revealed significantly low T scores in either the femur neck or L2–4 regions of patients with higher activity indices, but this difference was more prominent in the femur neck. In the early AS group (23 patients), 18 patients (78.26%) had L2–4 T scores lower than −1 SD, and in the advanced AS population, 19 of 30 patients (63.33%) had either osteopenia or osteoporosis (OP). We conclude that severe disease and concomitant urolithiasis might increase bone loss and fracture risk especially at the femur neck.
Similar content being viewed by others
References
Vilar MJP, Cury SE, Ferraz MB, Sess R, Atra E (1997) Renal abnormalities in ankylosing spondylitis. Scand J Rheumatol 26:19–23
Toussirot E, Wendling D (1996) Osteoporosis in ankylosing spondylitis. Presse Med 25(15):720–724
El Maghraoui A (2004) Osteoporosis and ankylosing spondylitis. Joint Bone Spine 71:291–295
Linden S, Heijde D (1998) Ankylosing spondylitis: clinical features. Rheum Dis Clin North Am 24:663–676
Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364–368
Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031–1035
Kanis AJ (1998) Osteoporosis. Blackwell, London, pp 1–22
Strobel ES, Fritschka E (1998) Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 17(6):524–530
Drach GW (1986) Urinary lithiasis. In: Campbell’s urology, vol II. Saunders, Philadelphia, p 1094
Paulus HE (1988) FDA arthritis advisory committee meeting: serious gastrointestinal toxicity of nonsteroidal antiinflammatory drugs, drug containing renal and biliary stones. Arthritis Rheum 31:1450–1451
Weber M, Braun B, Köhler H (1985) Ultrasonic findings in analgesic nephropathy. Nephron 39:216–222
Spirnack JP, Resnick MI (1988) Urinary stones. In: Smith’s general urology, 12th edn. Appleton & Lange, California, p 275
Cvijetic S, Füredi-Milhofer H, Babic-Ivancic V, Tucak A, Galic J, Dekanic-Ozegovic D (2002) Bone mineral density loss in patients with urolithiasis: a follow up study. Arch Med Res 33(2):152–157
Arinci Incel N, Incel N, Nacır B (2004) Bone mineral density and urolithiasis interaction in rheumatoid arthritis. J Bone Miner Metab 22:260–263
Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C (1994) Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 9:1525–1531
Marhoffer W, Stracke H, Masoud I, Scheja M, Graef V, Bolten W, Federlin K (1995) Evidence of impaired cartilage/bone turnover in patients with active spondylitis. Ann Rheum Dis 54:556–559
Sivri A, Kilinc S, Gökçe Kutsal Y, Ariyurek M (1996) Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15(1):51–54
Will R, Palmer R, Bhalla AK, Ring F, Calin A (1990) Bone loss as well as bone formation is a feature of ankylosing spondylitis. Br J Rheumatol 29:498–499
Donnelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD (1994) Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53:117–121
Mullaji AB, Upadhyay SS, Ho EKW (1994) Bone mineral density in ankylosing spondylitis. J Bone Joint Surg Br 76:660–665
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
İncel, N.A., Gökoğlu, F., Nacir, B. et al. Bone and stone in ankylosing spondylitis: osteoporosis and urolithiasis. Clin Rheumatol 25, 667–670 (2006). https://doi.org/10.1007/s10067-005-0114-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-005-0114-0